Andere talen Anebulo Pharmaceuticals, Inc.

Aandelen

ANEB

US0345691036

Beurs gesloten - Nasdaq Andere beurzen 19:30:00 03-07-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,4 ^USD	-3,61%		-8,75%	-0,83%

15/05	Anebulo Pharmaceuticals, Inc. rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 31 maart 2024	CI
13/02	Anebulo Pharmaceuticals, Inc. rapporteert resultaten voor het tweede kwartaal en de zes maanden eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	15/05
Anebulo Pharmaceuticals Reports Third Quarter Fiscal Year 2024 Financial Results and Recent Updates	15/05
Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	13/02
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates	13/02
Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	14/11
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates	14/11
Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors	09-10-23
Anebulo Pharmaceuticals Announces New CEO	09-10-23
Anebulo Pharmaceuticals Appoints New CEO	06-10-23
Anebulo Pharmaceuticals Announces New CEO	06-10-23
Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors	06-10-23
Anebulo Pharmaceuticals, Inc. Appoints Richie Cunningham as CEO	06-10-23
Anebulo Pharmaceuticals, Inc. Appoints Bimal Shah to Its Board of Directors	06-10-23
Anebulo Pharmaceuticals Appoints Daniel George as Part-Time Finance Chief	29-09-23
Anebulo Pharmaceuticals, Inc. Announces Chief Financial Officer Changes	29-09-23
Anebulo Pharmaceuticals, Inc. Appoints Daniel George as Principal Financial Officer and Principal Accounting Officer	29-09-23
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates	20-09-23
Anebulo Pharmaceuticals : Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates - Form 8-K	20-09-23
Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2023	20-09-23
Kronos Bio Appoints Sandra Gardiner as Interim Chief Financial Officer	18-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Anebulo Pharmaceuticals, Inc.

Aandelen

ANEB

US0345691036

Andere talen

Filters